Methodology optimization for KIR genotyping;Otimização de metodologia para o estudo de genes KIR

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 46, Issue 3, 2010, Pages 215-224

  Rudnick, Cristiane Conceição Chagas ^a   Guelsin, Gláucia Andréia Soares ^a   Marangon, Amanda Vansan ^a   Franceschi, Danilo Santana Alessio ^a   Sell, Ana Maria ^a   Visentainer, Jeane Eliete Laguila ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Genotyping; KIR; Natural killer cells; PCR SSO; PCR SSP

Indexed keywords

EID: 77956540767     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/s1676-24442010000300008     Document Type: Article

References (59)

1. BECKER, S. et al. Assessment of killer cell immunoglobulins receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. Hum Immunol, v. 64, n. 2, p. 183-93, 2003.
2. BERAN, M.; HANSSON, M.; KIESSLING, R. Human natural killer cells can inhibit clonogenic growth of fresh leukemic cells. Blood, v. 61, n. 3, p. 596-9, 1983.
3. BESSON, C. et al. Association of killer cell immunoglobulin-like receptor genes with Hodgkin's Lymphoma in a familial study. PLoSONE, v. 2, n. 5, e406, p. 1-10, 2007.
4. BIRON, C.A. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol, v. 9, n. 1, p. 24-34, 1997.
5. BONTADINI, A. et al. Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population. J Transl Med, v. 4, 44, 2006.
6. COLONNA, M. et al. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science, v. 260, n. 5111, p.1121-24, 1993.
7. th international histocompatibility workshop cell lines. Hum Immunol, v. 64, n. 5, p. 567-71, 2003.
8. COOK, M. A.; MOSS, P. A. H.; BRIGGS, D. C. The distribution of 13 killer-cell immunoglobulin-like receptor loci in UK blood donors from three ethnic groups. Eur J Immunogenet, v. 30, n. 3, p. 213-21, 2003.
9. CRUM, K. A. et al. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens, v. 56, n. 4, p. 313-26, 2000.
10. DE OLIVEIRA, D. C. M. et al. Identificação dos genótipos KIR na população brasileira. Rev Bras Hematol Hemoter, v. 28, Suppl. 1, p. 22-34, 2006.
11. DENIS, L. et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion. Tissue Antigens, v. 66, n. 4, p. 267-76, 2005.
12. DYNAL. Tissue typing Dynal-SSP. Technical handbook. ed. Norway, 1996. 63 p.
13. EWERTON, P. D. et al. Amazonian Amerindians exhibit high variability of KIR profiles. Immunogenetics, v. 59, n. 8, p. 625-30, 2007.
14. FLORES, A. C. et al. KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. Tissue Antigens, v. 69, n. 6, p. 568-76, 2007.
15. FLORES-VILLANUEVA, P. O. et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA, v. 98, n. 9, p. 5140-5, 2001.
16. FRASSATI, C. et al. Distribution of killer-cell immunoglobulin-like receptor (KIR) in Comoros and Southeast France. Tissue Antigens, v. 67, n. 5, p. 356-67, 2006.
17. GARCIA, C.A. et al. Human KIR sequences 2003. Immunogenetics, v. 55, n. 4, p.227-39, 2003.
18. GENDZEKHADZE, K. et al. High KIR diversity in Amerindians is maintained using few gene-content haplotypes. Immunogenetics, v. 58, n. 5-6, p. 474-80, 2006.
19. GÓMEZ-LOZANO, N. et al. Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics, v. 54, n. 5, p. 314-9, 2002.
20. GÓMEZ-LOZANO, N.; VILCHES, C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens, v. 59, n. 3, p. 184-93, 2002.
21. GUTIÉRREZ-RODRÍGUEZ, M. E. et al. KIR gene in ethnic and mestizo populations from Mexico. Hum Immunol, v. 67, n. 1-2, p. 85-93, 2006.
22. HAYAKAWA, Y.; SMYTH, M. J. Innate immune recognition and suppression of tumors. Adv Cancer Res, v. 95, p.293-322, 2006.
23. HERCEND, T. et al. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood, v. 67, n. 3, p. 722-8, 1986.
24. HSU, K.C. et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol, v. 169, n. 9, p. 5118-29, 2002.
25. IPD-KIR DATABASE. Disponível em: . Acesso em: 29 out. 2009.
26. JENNES, W. et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol, v. 177, n. 10, p. 6588-92, 2006.
27. JIANG, K. et al. Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. Tissue Antigens, v. 65, n. 6, p. 556-63, 2005.
28. JONES, D. C. et al. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility. Genes Immun, v. 7, n. 7, p. 576-82, 2006.
29. KÄRRE, K. NK cells, MHC class I molecules and missing self. Scand J Immunol, v. 55, n. 3, p. 221-8, 2002.
30. KHAKOO, S. I. et al. HLA and NK cell inhibitory receptorgenes in resolving Hepatitis C virus infection. Science, v. 305, n. 5685, p. 872-4, 2004.
31. LANIER, L. L. NK cell receptors. Annu Rev Immunol, v.16, p. 359-93, 1998.
32. LÓPEZ-VÁZQUEZ, A. et al. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum Immunol, v. 66, n. 3, p. 285-9, 2005.
33. LUSZCZEK, W. et al. Inhibitory and activatory KIR gene frequencies in the Polish population. Int J Immunogenet, v. 33, n. 3, p. 167-70, 2006.
34. MAHFOUZ, R. et al. Distribution of killer cell immunoglobulin-like receptors genotypes in the Lebanese population. Tissue Antigens, v. 68, n. 1, p. 66-71, 2006.
35. MARSH, S. G. E. et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics, v. 55, n. 4, p. 220-6, 2003.
36. MARTIN, M. P. et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet, v. 31, n. 4, p. 429-34, 2002.
37. MARTIN, M. P. Tipagem de genes KIR e sua aplicaçãoem estudos de populações, associação com doenças e transplantes. In: VIII CONGRESSO DA SOCIEDADE BRASILEIRA DE TRANSPLANTE DE MEDULA ÓSSEA, 2004, Curitiba.
38. MAXWELL, L. D. et al. Investigation of KIR diversity in immunosenecence and longevity within the Irish population. Exp Gerontol, v. 39, n. 8, p. 1223-32, 2004.
39. MORETTA, A. et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med, v. 182, n. 3, p. 875-84, 1995.
40. NIOKOU, D. et al. Distribution of killer cell immunoglobulin-like receptors in the Greek population. Hum Immunol, v. 64, n. 12, p. 1167-76, 2003.
41. NONG, T. et al. KIR genotyping by reverse sequence-specific oligonucleotide methodology. Tissue Antigens, v. 69, Suppl. 1, p. 92-5, 2007.
42. NORMAN, P. J. et al. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics, v. 52, n. 3-4, p. 195-205, 2001.
43. NORMAN, P. J. et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun, v. 3, n. 2, p. 86-95, 2002.
44. PROMEGA. PCR core systems. Technical bulletin. N. 254 USA, 2001. 20 p.
45. RAJALINGAM, R. et al. Distinctive KIR and HLA diversity in a panel of north Indian Hindus. Immunogenetics, v. 53, n. 12, p. 1009-19, 2002.
46. RAJALINGAM, R. et al. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens, v. 57, n. 1, p. 22-31, 2001.
47. RUDNICK, C. C. et al. Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná. Hum Immunol, v. 69, n. 12, p. 872-6, 2008.
48. RUGGERI, L. et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood, v. 94, n. 1, p. 333-39, 1999.
49. SANTIN, I. et al. Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type I Diabetes Mellitus. Hum Immunol, v. 67, n. 1-2, p. 118-24, 2006.
50. SHILLING, H. G. et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol, v. 168, n. 5, p. 2307-15, 2002.
51. SUN, J.Y. et al. Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens, v. 64, n. 4, p. 462-68, 2004.
52. TONEVA, M. et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens, v. 57, n. 4, p. 358-62, 2001. (Pubitemid 32511307)
53. UHRBERG, M. et al. Human diversity in killer cell inhibitory receptor genes. Immunity, v. 7, n. 6, p. 753-63, 1997.
54. VELICKOVIC, M.; VELICKOVIC, Z.; DUNCKLEY, H. Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations. Immunogenetics, v. 58, n. 7, p. 523-32, 2006.
55. WHANG, D. H. et al. Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families. Hum Immunol, v. 66, n. 2, p. 146-154, 2005.
56. WILSON, M. J. et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA, v. 97, n. 9, p. 4778-83, 2000.
57. WITT, C. S. et al. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation, v. 68, n. 11, p. 1784-89, 1999.
58. YANG, Q. et al. Antitumor activity of NK cells. Immunol Res, v. 36, n. 1-3, p. 13-25, 2006.
59. YAWATA, M. et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics, v. 54, n. 8, p. 543-50, 2002.